1Kouloulias VE,Kouvaris JR,Nikita KS,et al.Intraoperative hyperthermia in conjunction with multi-schedule chemotherapy(pre-,intra-and post-operative),by-pass surgery,and postoperative radiotherapy for the management of unresectable pancreatic adenocarcinom
2Cohen SJ,Ho L,Ranganathan S,et al.Phase Ⅱ and pharmacodynamic study of the farnesyltransferase inhibitor R115777 as initial therapy in patients with metastatic pancreatic adenocarcinoma.J Clin Oncol,2003,21 :1301-1306.
3Papachristou E,Link KH,Schoenberg MH.Regional celiac artery infusion in the adjuvant treatment of pancreatic cancer.Anticancer Res,2003,23(2A):831-834.
4Bayar S,Unal E,Tez M,et al.Regional chemotherapy for advanced pancreatic carcinoma.Hepatogastroenterology,2003,50:550-552.
5Haller DG.New perspectives in the management of pancreas cancer.Semin Oncol,2003,30(4 Suppl 11):3-10.
6Picozzi VJ,Kozarek RA,Traverso LW.Interferon-based adjuvant chemoradiation therapy after pancreaticoduodenectomy for pancreatic adenocarcinoma.Am J Surg,2003,185:476-480.
7Vogl T J,Heller M,Zangos S,et al.Transarterial chemoperfusion of inoperable pancreas carcinoma and local recurrence.Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr,2003,175:695-704.
8Mohiuddin M,Cantor RJ,Biermann W,et al.Combined modality treatment of localized unresectable adenocarcinoma of the pancreas.Int J Radiat Oncol Biol Phys,1988,14:79-84.
9Kovach S J,Hendrickson R J,Cappadona CR,et al.Cryoablation of unresectable ancreatic cancer.Surgery,2002,131:463-464.
10Patiutko I,Barkanov AI,Kholikov TK,et al.The combined treatment of locally disseminated pancreatic cancer using cryosurgery.Vopr Onkol,1991,37:695-700.
7Michael B. Farnell,Gerard V. Aranha,Yuji Nimura,Fabrizio Michelassi.The Role of Extended Lymphadenectomy for Adenocarcinoma of the Head of the Pancreas: Strength of the Evidence[J]. Journal of Gastrointestinal Surgery . 2008 (4)
8Muscari F,Suc B,Kirzin S,et al.Risk factors for mortality and intra-ab-dominal complications after pancreatoduodenectomy:multivariate analysisin 300 patients〔J〕. Journal of Surgery . 2006
9Shibata K,Iwaki K,Kai S,et al.Increased levels of both carbohydrate an-tigen 19-9 and duke pancreatic monoclonal antigen type 2 reflect postop-erative prognosis in patients with pancreatic carcinoma〔J〕. Pancreas . 2009
10Tawada K,Ishihara T,Kobayashi A,et al.Quantitative analysis of vascu-lar endothelial growth factor in liver metastases from pancreatic carcinomaas a predictor of chemotherapeutic effect and prognosis〔J〕. Clinical Cancer Research . 2008
